Search research articles
Contact Us
Filters
Showing results (621-630 of 1,117) with videos related to
Page
of 112
Sort By:
Scientific Reports
|
August 26, 2024
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Mimma Rizzo, Andrey Soares, Enrique Grande, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study
Carlo Messina, Martina Catalano, Giandomenico Roviello, et al.
European Urology
|
September 16, 2022
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer
Christina Guo, Ines Figueiredo, Bora Gurel, et al.
Frontiers in Oncology
|
August 11, 2025
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
Maria T Bourlon, Luca Galli, Enrique Grande, et al.
Gut
|
November 18, 2025
Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis
Lena Smets, Maria Francesca Viola, Markus Boesch, et al.
Cancer Cell
|
November 22, 2024
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer
George Seed, Nick Beije, Wei Yuan, et al.
Nature Medicine
|
October 31, 2019
Author Correction: Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
Andrew Maltez Thomas, Paolo Manghi, Francesco Asnicar, et al.
Frontiers in Oncology
|
February 27, 2024
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: <i>post-hoc</i> analysis of the Meet-URO 15 study
Veronica Murianni, Alessio Signori, Sebastiano Buti, et al.
Nature Medicine
|
April 3, 2019
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
Andrew Maltez Thomas, Paolo Manghi, Francesco Asnicar, et al.
Cancer Immunology, Immunotherapy : CII
|
May 27, 2025
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)
Matteo Santoni, Giandomenico Roviello, Enrique Grande, et al.
Page
of 112
Search research articles
Search
Showing results (621-630 of 1,117) with videos related to
Sort By:
Page
of 112
Scientific Reports
|
August 26, 2024
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Mimma Rizzo, Andrey Soares, Enrique Grande, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study
Carlo Messina, Martina Catalano, Giandomenico Roviello, et al.
European Urology
|
September 16, 2022
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer
Christina Guo, Ines Figueiredo, Bora Gurel, et al.
Frontiers in Oncology
|
August 11, 2025
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
Maria T Bourlon, Luca Galli, Enrique Grande, et al.
Gut
|
November 18, 2025
Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis
Lena Smets, Maria Francesca Viola, Markus Boesch, et al.
Cancer Cell
|
November 22, 2024
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer
George Seed, Nick Beije, Wei Yuan, et al.
Nature Medicine
|
October 31, 2019
Author Correction: Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
Andrew Maltez Thomas, Paolo Manghi, Francesco Asnicar, et al.
Frontiers in Oncology
|
February 27, 2024
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: <i>post-hoc</i> analysis of the Meet-URO 15 study
Veronica Murianni, Alessio Signori, Sebastiano Buti, et al.
Nature Medicine
|
April 3, 2019
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
Andrew Maltez Thomas, Paolo Manghi, Francesco Asnicar, et al.
Cancer Immunology, Immunotherapy : CII
|
May 27, 2025
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)
Matteo Santoni, Giandomenico Roviello, Enrique Grande, et al.
Page
of 112